Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Adams

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Pharmacology & Therapeutics|February 1, 2011
Structure, function and pathophysiology of protease activated receptorsMark N Adams, Rithwik Ramachandran, Mei-Kwan Yau, et al.
Pharmaceuticals (Basel, Switzerland)|September 30, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Connor O'Leary, Harry Gasper, Katherine B Sahin, et al.
Nucleic Acids Research|June 14, 2017
A data-driven structural model of hSSB1 (NABP2/OBFC2B) self-oligomerizationChristine Touma, Mark N Adams, Nicholas W Ashton, et al.
Seminars in Cell & Developmental Biology|March 27, 2018
Human single-stranded DNA binding protein 1 (hSSB1, OBFC2B), a critical component of the DNA damage responseLaura V Croft, Emma Bolderson, Mark N Adams, et al.
Journal of Cell Science|July 14, 2018
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell modelsSamantha J Stehbens, Robert J Ju, Mark N Adams, et al.
Cancers|March 6, 2021
COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic TargetAmila Suraweera, Pascal H G Duijf, Christian Jekimovs, et al.
Frontiers in Oncology|May 9, 2024
The expression and role of the Lem-D proteins Ankle2, Emerin, Lemd2, and TMPO in triple-negative breast cancer cell growthMaddison Rose, Joshua T Burgess, Chee Man Cheong, et al.
Biological Chemistry|May 24, 2014
Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidasesYing Dong, Brittney S Harrington, Mark N Adams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2017
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung CancerMark N Adams, Joshua T Burgess, Yaowu He, et al.
British Journal of Cancer|May 23, 2020
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Pharmacology & Therapeutics|February 1, 2011
Structure, function and pathophysiology of protease activated receptorsMark N Adams, Rithwik Ramachandran, Mei-Kwan Yau, et al.
Pharmaceuticals (Basel, Switzerland)|September 30, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)Connor O'Leary, Harry Gasper, Katherine B Sahin, et al.
Nucleic Acids Research|June 14, 2017
A data-driven structural model of hSSB1 (NABP2/OBFC2B) self-oligomerizationChristine Touma, Mark N Adams, Nicholas W Ashton, et al.
Seminars in Cell & Developmental Biology|March 27, 2018
Human single-stranded DNA binding protein 1 (hSSB1, OBFC2B), a critical component of the DNA damage responseLaura V Croft, Emma Bolderson, Mark N Adams, et al.
Journal of Cell Science|July 14, 2018
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell modelsSamantha J Stehbens, Robert J Ju, Mark N Adams, et al.
Cancers|March 6, 2021
COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic TargetAmila Suraweera, Pascal H G Duijf, Christian Jekimovs, et al.
Frontiers in Oncology|May 9, 2024
The expression and role of the Lem-D proteins Ankle2, Emerin, Lemd2, and TMPO in triple-negative breast cancer cell growthMaddison Rose, Joshua T Burgess, Chee Man Cheong, et al.
Biological Chemistry|May 24, 2014
Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidasesYing Dong, Brittney S Harrington, Mark N Adams, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 11, 2017
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung CancerMark N Adams, Joshua T Burgess, Yaowu He, et al.
British Journal of Cancer|May 23, 2020
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Pageof 6